Risk factors for multidrug resistance and mortality in healthcare-associated neonatal gram-negative bloodstream infections
Hatice Turgut, Ramazan Özdemir, Funda Memişoğlu · 2026
Read Risk factors for multidrug resistance and mortality in healthcare-associated neonatal gram-negative bloodstream infections by Hatice Turgut, Ramazan Özdemir, Funda Memişoğlu (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13593627.txt.
Description
Hatice Turgut and colleagues named risk factors for drug toughness and death in newborn blood cases in a Turkish critical-care unit. Gram-negative sepsis kills many babies, and multi-drug toughness tangles treatment. Their look-back cohort study read 197 babies with hospital-linked gram-negative blood cases found between 2010 and 2025.
Multi-drug toughness hit fifty-seven point nine percent, led by Klebsiella at fifty-one point three percent of samples. Wide enzyme output reached sixty-eight point six percent, and carbapenem toughness hit thirty-nine point one percent. Acinetobacter showed the highest drug toughness and multi-drug rates. Older age at onset, breathing machines, and prior drug use flagged toughness, while right early therapy shielded against it. Overall forty-two point one percent died within 28 days, driven by sickness rather than toughness itself. The authors stress right first-guess therapy.
Catalog record
| CREATOR | Hatice Turgut, Ramazan Özdemir, Funda Memişoğlu |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 44 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |